Financhill
Back

Citius Pharmaceuticals Quote, Financials, Valuation and Earnings

Citius Pharmaceuticals Price Quote

$0.33
+0.00 (+-14.44%)
(Updated: November 15, 2024 at 4:08 AM ET)

Citius Pharmaceuticals Key Stats

Sell
31
Citius Pharmaceuticals (CTXR) is a Sell

Day range:
$0.25 - $0.37
52-week range:
$0.25 - $1.07
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.69%

Volume:
5.5M
Avg. volume:
1.3M
1-year change:
-57.52%
Market cap:
$59.4M
Revenue:
$0
EPS:
$-0.24

How Much Does Citius Pharmaceuticals Make?

Data Unavailable

Is Citius Pharmaceuticals Growing As A Company?

Data Unavailable

Citius Pharmaceuticals Stock Price Performance

What Is Citius Pharmaceuticals 52-Week High & Low?

Citius Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Citius Pharmaceuticals?

Is Citius Pharmaceuticals Cash Flow Positive?

  • What Is CTXR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$29.1M
  • What Is Citius Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Citius Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Citius Pharmaceuticals Return On Invested Capital

Data Unavailable

Citius Pharmaceuticals Earnings Date & Stock Price

Citius Pharmaceuticals Competitors

Citius Pharmaceuticals Dividend Yield

Citius Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -33.33%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 4.67
Upside from Last Price: 1321.03%

Major Shareholders

  • How many CTXR shares are owned by institutional investors?
    38.2M CTXR shares are owned by institutional investors
  • How many CTXR shares are owned by insiders?
    12.3M CTXR shares are owned by insiders